Sargent Bickham Lagudis LLC Takeda Pharmaceutical CO LTD Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
Shares
3 transactions
Others Institutions Holding TAK
# of Institutions
338Shares Held
76.2MCall Options Held
1.85MPut Options Held
121K-
Capital Research Global Investors Los Angeles, CA13.1MShares$175 Million0.04% of portfolio
-
Mondrian Investment Partners LTD London, X012.1MShares$161 Million2.47% of portfolio
-
Morgan Stanley New York, NY5MShares$66.7 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.21MShares$56.2 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.12MShares$41.7 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $41.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...